Suchergebnisse - "Xie, Lin"

PubPharm (21)

1

Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)

enthalten in: Clinical drug investigation | 2024

von Tan, X. | Divino, V. | Amamoo, J. | +6

2

Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors : cardiovascular effects in people with diabetes and cardiovascular disease

enthalten in: Cardiovascular diabetology | 2023

von Tan, X. | Liang, Y. | Rajpura, J. | +5

3

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin

enthalten in: Diabetes, obesity & metabolism | 2018

von Zhou, F. | Xie, L. | Pan, C. | +5

4

The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies : Findings from the INITIATOR Study

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2017

von Brekke, L. | Buysman, E. | Grabner, M. | +4

5

Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States : Implications for Treatment Discontinuation and Healthcare Costs and Utilization

enthalten in: Advances in therapy | 2017

von Dalal, M. | Kazemi, M. | Ye, F. | +1

6

A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies

enthalten in: Diabetes, obesity & metabolism | 2017

von Wei, W. | Buysman, E. | Grabner, M. | +5

7

Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United States

enthalten in: Journal of medical economics | 2016

von Cai, J. | Wang, Y. | Baser, O. | +2

8

Beyond knockout : A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice

enthalten in: Metabolism: clinical and experimental | 2016

von Zhang, X. | Xing, S. | Li, M. | +7

CommentIn: Metabolism. 2016 Sep;65(9):1278-85. - PMID 27506735

9

Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin : Outcomes in a Community Setting

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2015

von Dalal, M. | Xie, L. | Baser, O. | +1

CommentIn: Endocr Pract. 2015 Jan;21(1):88-90. - PMID 25628120

10

Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan : a claims database analysis

enthalten in: Diabetes technology & therapeutics | 2014

von Xie, L. | Zhou, S. | Pinsky, B. | +2